Local IFNα enhances the anti-tumoral efficacy of systemic anti-PD1 to prevent tumor relapse
Background Tumor relapse constitutes a major challenge for anti-tumoral treatments, including immunotherapies. Indeed, most cancer-related deaths occur during the tumor relapse phase.Methods We designed a mouse model of tumor relapse in which mice transplanted with E7+ TC1 tumor cells received a sin...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2020-10-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/8/2/e000996.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|